| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -9.09M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SLNCF returned +150.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +100.0% |
| 1 year | +150.0% |
| 5 years | -43.2% |
| 10 years | +193.3% |
| All-time high | $9.25 (May 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SLNCF would be worth today ›No. Silence Therapeutics plc has not paid a dividend in the past 12 months.
Silence Therapeutics plc is part of the Healthcare sector.
Silence Therapeutics plc has a market cap of 820.43M USD, based on the latest quote.
